Patents by Inventor Shih-Hen Liu

Shih-Hen Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HLA-A2-RESTRICTED T-CELL EPITOPES OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN AS PEPTIDE-BASED VACCINES
    Publication number: 20100172925
    Abstract: Respiratory syncytial virus (RSV) fusion protein-specific T-cell epitopes as peptide-based vaccines are disclosed. The isolated peptide contains a human HLA restricted CD8+ T-cell epitope that is specific to RSV F protein. The length of the peptide is no more than 9 or 10 amino acid residues. The peptide may be employed as an immunogen to stimulate cytotoxic T cells, indirectly activate helper T cells type 1, and cause release of cytokines from T cells.
    Type: Application
    Filed: December 29, 2009
    Publication date: July 8, 2010
    Applicant: NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: YEN-HUNG CHOW, Shih-Hen Liu, Pele Choi-Sing Chong